A Source Close to the Matter Said the Funding Round Had Valued Atai at About $2 Billion, Adding That the Company Was Considering Floating on the U.S. Stock Market in May Berlin biotech startup Atai Life Sciences , which is exploring the use of Psychedelic treatments for depression, anxiety and addiction, on Wednesday said that it had raised . Conduct extensive due diligence and prepare investment proposals for atai's investment committee and other key stakeholders. This Berlin company develops novel treatments for mental health issues like depression, PTSD, anxiety and addiction. Those long-lasting effects mean that . Equal Opportunity Employer At atai . Mydecine has announced two near-term Phase II clinical trials studying its MYCO-001 lead drug . Weather . Full-Time. Rankings. Our website address is www.atai.life. atai Life Sciences is a biopharmaceutical company focused on developing novel treatments for mental health disorders so that everyone, everywhere can live a . We are looking for a passionate, driven and multitalented Executive Assistant (EA) 2.0 Bosque Foods GmbH Biotechnology Internship Berlin Easy Apply 3d Position: Full-time. Looking at the changes and additions in Apple's latest mobile software, there's not much to point to in major design changes or UI overhauls; at the same time, Apple doesn't seem to have made the kind of game-changing performance and battery life improvements that defined quieter updates like iOS 12, or iOS 10's changes to how it lets third-party apps hook into the OS. In 2019, he featured in the Channel 4 series The Secret Teacher, going undercover at a school near Liverpool as a teacher. In May 2021, it was confirmed that Bartlett, aged 28, would be the youngest-ever investor on the long . After the giant success of Compass Pathways (CMPS.N) IPO this Peter Thiel-backed company (and current Compass partner) is looking for a similar outcome.. Cybin (CYBN.NE) is working to eliminate the single most annoying part of every mushroom trip As atai is pursuing multiple commercialization pathways (out-license post POC, self-commercialization) this role will be responsible for compiling the commercial story for early-stage assets (PhI, PhII) in support of out-licensing in addition to potentially self-commercialized assets. We are headquartered in Berlin, with offices in New York, San Diego and London. The Berlin-based company . NEW YORK, May 04, 2022 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) ("atai"), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders,. atai was founded in 2018 as a response to the significant unmet need and lack of innovation in the mental health treatment landscape. All employment is decided on the basis of qualifications, merit, and business need. Firm Profile. News & Insights. Discover the latest ATAI Life Sciences N.V. (ATAI) news, stock quote, history, research and more. As a result of the investment, atai now holds approximately 25% of the issued and . ATAI Life Sciences B.V.* (Exact Name of Registrant as Specified in its Charter) . Atai Life Sciences . We are developing psychedelic and non-psychedelic compounds and cutting-edge digital therapeutic tools, and are excited about anything that might mean a true leap forward for patients. It's a lifestyle that looks beautiful from the outside and, as many vanlifers' positive outlook suggests, often is during their travels but it comes with a great deal of less glamorous . atai Life Sciences is a biopharmaceutical company focused on developing novel treatments for mental health disorders so that everyone, everywhere can live a more fulfilled life. Posted: June 27, 2021. berlin and san diego, sept. 09, 2021 (globe newswire) -- atai life sciences (nasdaq: atai) ("atai"), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health. Our vision is to heal mental health disorders so that everyone everywhere can live a more fulfilled life. Serve as asset manager to new and existing assets and . atai is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. To learn more about our values and how we operate click here. atai Life Sciences is a biopharmaceutical company focused on developing novel treatments for mental health disorders so that everyone, everywhere can live a more fulfilled life. Save Job. atai is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. New York, NY. Position: Full-time. atai is dedicated to acquiring, incubating and efficiently developing innovative therapeutics to We want to transform the patient experience in mental health care. The statutory seat of ATAI Life Sciences B.V. is in Amsterdam, the Netherlands. This list of early stage venture investors headquartered in Germany provides data on their investment activities, fund raising history, portfolio companies, and recent news. We are headquartered in Berlin, with offices in New York, San Diego and London. The company is a clinical-stage biopharmaceutical firm aiming to transform the treatment of mental health . (Reuters) -Shares of Atai Life Sciences B.V., backed by billionaire investor Peter Thiel, surged 40% in their U.S. stock market debut on Friday, giving the German psychedelics startup a market . ATAI Life Sciences N.V. . To learn more about our values and how we operate click here. Shares of Atai Life Sciences B.V. , backed by billionaire investor Peter Thiel, surged 40% in their U.S. stock market debut on Friday, giving the German psychedelics startup a market capitalization of $3.19 billion. Additionally, any future collaborations we enter into with third parties may provide capital in the near term, but limit our potential cash flow and . atai Life Sciences is a biopharmaceutical company focused on developing novel treatments for mental health disorders so that everyone, everywhere can live a more . Most Relevant 111 biology Jobs in Berlin 3.0 Formo Executive Assistant (m/f/x) to the C-level Berlin Easy Apply 24h A passion for challenging the status quo and transforming the food industry. Atai Life Sciences, which is headquartered in Berlin, Germany, completed its Nasdaq IPO. As atai is focusing in on innovate medicine with new MoAs . new york and berlin, jan. 27, 2022 (globe newswire) -- atai life sciences n.v. (nasdaq: atai) ("atai"), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today launched invyxis, a new, wholly owned platform company committed to developing new chemical entities (nces) and to further pioneering atai Life Sciences is a biopharmaceutical company focused on developing novel treatments for mental health disorders so that everyone, everywhere can live a more fulfilled life. VP of Business Development (f/m/d) atai. Show Salary Details. ATAI Life Sciences. Operations Director / Senior Director - Product Supply. Employer Identification No.) ATAI Life Sciences AG sucht Director, Investments & Venture Management in Berlin, Berlin, Deutschland | LinkedIn Director, Investments & Venture Management ATAI Life Sciences AG Berlin Auf. Berlin, Germany (Address of principal executive offices) (Zip Code) +49 89 2153 9035 . Intellectual Property (IP) Patent Agent (f/m/d) atai. We operate a decentralized model whereby atai incubates, acquires, and supports individual platform companies by providing them strategic and operational functions . In November 2020, billionaire Peter Thiel invested $12 million (USD) into Atai Life Sciences. Full-Time. We have offices in Berlin, London . Our vision is to heal mental health disorders so that everyone everywhere can live a more fulfilled life. BERLIN, Sept. 03, 2021 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) ("atai"), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced that it will participate in in the following upcoming investor conferences in September: Presentation details can be found below: Citi 16th Annual BioPharma ConferenceFormat . Liam has joined a number of other prominent figures in investing in Atai Life Sciences, including American DJ Diplo, real name Thomas Pentz, 42, and new Dragons' Den star Steve Bartlett, 28. Recreational use of psychedelics became popular in the 1960s, but it didn't take long for the US government to classify most of them as . Go to. CCFD investigates smoke sighting near Apex landfill 1 hour ago Video. Email firm Visit website 49 30 264 73 0 49 30 264 73 133. Our first programme is researching how COMP360 psilocybin therapy could help people with treatment-resistant depression. New London, CT. Posted: June 27, 2021. The Berlin-based biotech startup, which is exploring the use of psychedelic treatments for mental illnesses, raised $225 million from selling 15 million shares in its upsized . New London, CT. Posted: June 27, 2021. With tentacles in Berlin, New York and Amsterdam, atai has raised large amounts of backing to finance research and development of new psychiatric medicines and related technologies. SAINT LAURENT, Quebec, May 14, 2021 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQB:IGXT) ("IntelGenx"), a leader in pharmaceutical films, today reported that the previously announced US$12,346,300 investment in IntelGenx by ATAI Life Sciences AG ("atai") has been completed. Location: New York; London; Berlin. atai Life Sciences is a biopharmaceutical company focused on developing novel treatments (both psychedelic and non-psychedelic) for mental health disorders so that everyone, everywhere can live a more fulfilled life. VP of Business Development (f/m/d) atai. Atai Life Sciences (NASDAQ: ATAI) NASDAQ: ATAI | USD $3.69 | -1.34% atai is a global biotechnology 'company builder', seeking to acquire and develop mental health treatments.With tentacles in Berlin, New York and Amsterdam, atai has raised large amounts of backing to finance research and development of new psychiatric medicines and related technologies. atai was founded in 2018 as a response to the significant unmet need and lack of. chief scientific officer of Atai Life Sciences, a mental health drug company that owns a 21% stake in Compass Pathways. NEW YORK and BERLIN, May 16, 2022 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) ("atai"), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today reported financial results for the quarter ended March 31, 2022 and provided a business update. Shares of Atai Life Sciences B.V. , backed by billionaire investor Peter Thiel, surged 40% in their U.S. stock market debut on Friday, giving the German psychedelics startup a market . They're finding success with compounds such as psilocybin, MDMA and its derivatives, and ibogaine. atai Life Sciences is a biopharmaceutical company focused on developing novel treatments for mental health disorders so that everyone, everywhere can live a . Would it be better if I went to college for Biotech then did a bachelors in computer science (combing the fields to get a better paying job)? Atai Life Sciences (NASDAQ: ATAI) has announced the launch of a new subsidiary that will research Salvinorin A, the active compound in salvia divinorum, a hallucinogenic herb native to Central . new york and berlin, jan. 27, 2022 (globe newswire) atai life sciences n.v. (nasdaq: atai) ("atai"), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today launched invyxis, a new, wholly owned platform company committed to developing new chemical entities (nces) and to further pioneering VP of Business Development (f/m/d) atai. The office address of ATAI Life Sciences B.V. and our principal executive office is located at Krausenstrae 9-10, 10117 Berlin, Germany, and our telephone number is +49 89 2153 9035. Full-Time. You are comfortable working with a global team across time zones, different cultures, and 3.4 Meditrial Europe Ltd. Clinical Project Manager Berlin Easy Apply 30d+ . Vanlifers are known for dropping their office jobs, traveling the world, and posting picture-perfect (and sponsor-friendly) images along the way. Atai Life Sciences NV SEC filing: Form 10-K on 03/29/2022 (0000950170-22-005013). Location: New York; London; Berlin. Not Applicable (Address of principal executive offices) (Zip Code) . Condensed Consolidated Balance Sheets; Condensed Consolidated Balance Sheets (Parenthetical) Condensed Consolidated Statements of Operations . ATAI Life Sciences, a German biotech startup focused on depression and other mental health disorders, raised $43m in Series B funding. A company backed by new Dragons' Den star and Social Chain co-founder Steven Bartlett has listed on a US stock exchange. ATAI Life Sciences. Discover the latest ATAI Life Sciences N.V. (ATAI) news, stock quote, history, research and more. . TrueUp scans 470,000+ open tech jobs from all top startups, unicorns, and big tech to give you the inside track on the best ones for you. Equal Opportunity Employer At atai . atai Address Berlin, NH 03570 USA Industry Finance and Insurance View all jobs at atai Report Job Other Helpful Pages Related To VP Investor Relations All Jobs VP Investor Relations Jobs Psychedelic drugmaker ATAI Life Science, which backed by billionaire investor Peter Thiel, said it is planning to raise $100 million in an initial public offering. atai is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Lawyer Profiles. We operate a decentralized model whereby atai incubates . Atai Life Sciences Location: Berlin . Srinivas Rao Co-Founder & Chief Scientific Officer at ATAI Life Sciences AG Encinitas, California, United States 500+ connections DentonsMARKGRAFENSTRASSE 3310117 BERLINGermany. atai Life Sciences also owns a significant stake in Compass . ATAI Life Sciences, a biosciences company backed by billionaire Peter Thiel that specializes in experimental treatment of mental disorders with psychedelic drugs, has bought out a majority stake . Atai Life Sciences NV SEC filing: Form 10-K on 03/29/2022 (0000950170-22-005013). 10117 Berlin, Germany +49 89 2153 9035 (Address, including zip code, and telephone number, including area code, of Registrant's principal executive offices . Main Contacts. We are developing psychedelic and non-psychedelic compounds and cutting-edge digital therapeutic tools. Atai Life Sciences, which is headquartered in Berlin, Germany, has completed its Nasdaq IPO. Berlin, Germany. Atai Life Sciences, which is headquartered in Berlin, Germany, completed its Nasdaq IPO. The company is a clinical-stage biopharmaceutical firm aiming to transform the treatment of mental health disorders. ATAI Life Sciences N.V. ("ATAI") is the parent company of ATAI Life Sciences AG and, along with its subsidiaries, is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. The psychedelics investor community is buzzing around a potential ATAI Life Sciences IPO coming in 2021. Position: Full-time. (I.R.S. Print Document View Excel Document: Financial Statements. Steven Bartlett. NEW YORK, April 19, 2022 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) ("atai"), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, will participate in the following upcoming investor conference in April: The presentation and archived webcast will also be accessible in the . Those long-lasting effects mean that someone on the therapy will spend an entire day tripping in a doctor's office and away from work or other . Florian Brand is the Co-founder and Chief Executive Officer of atai Life Sciences, a global biotech company builder with the vision of ultimately ending mental health disorders.. Chief Executive Officer & Co-founder - atai Life Sciences It is now the highest valued company in the space, valued at $240m. Comp360's psychedelic effects are long lasting, says Srinivas Rao, chief scientific officer of Atai Life Sciences, a mental health drug company that owns a 21% stake in Compass Pathways. "We made great progress in the . 10117 Berlin, Germany +49 89 2153 9035 (Address, including zip code, and telephone number, including area code, of Registrant's principal executive offices) . Peppermint VenturePartners was established in 2008 by Ingeborg Neumann, Dr. Joachim Rautter and Dr. Klaus Stckemann.. Vice President, Business Development. Condensed Consolidated Balance Sheets; Condensed Consolidated Balance Sheets (Parenthetical) Condensed Consolidated Statements of Operations . "We made great progress in the . NEW YORK, May 04, 2022 (GLOBE NEWSWIRE) atai Life Sciences N.V. (Nasdaq: ATAI) ("atai"), a clinical-stage biopharmaceutical company aiming . Save Job. R-ketamine is a stereoisomer of ketamine being . 8 comments. NEW YORK and BERLIN, May 16, 2022 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) ("atai"), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today reported financial results for the quarter ended March 31, 2022 and provided a business update. atai Impact is committed to advancing education, expanding access and supporting the wider ecosystem of mental health careNEW YORK and BERLIN, Oct. 19, 2021 (GLOBE NEWSWIRE) -- atai Life Sciences (Nasdaq: ATAI) ("atai"), a clinical-stage biopharmaceutical company, today announced the launch of its new philanthropic program, atai Impact, in line with atai Life Sciences' vision, to heal . . save. Organizations in this hub have their headquarters located in Germany, Europe; notable events and people located in Germany are also included. Read additional news coverage at Science Magazine. Vice President, Business Development. Millions of exclusive tech data points. atai Life Sciences is a biopharmaceutical company focused on developing novel treatments for mental health disorders so that everyone, everywhere can live a more fulfilled life. PSYCH MONEY: Two European psychedelics companies had IPOs this week: atai Life Sciences, from Berlin, and GH Research, of Dublin. share. #2: ATAI. We are developing psychedelic and non-psychedelic compounds and cutting-edge digital therapeutic tools, and are excited about anything that might mean a true leap forward for patients. . atai is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Demonstrates atai's confidence in COMPASS' Phase 2b data and its potential for patients with treatment-resistant depression Reinforces COMPASS as highly complementary to atai's diversified approach to innovation in mental health NEW YORK, Nov. 29, 2021 (GLOBE NEWSWIRE) -- atai Life Sciences (Nasdaq: ATAI) ("atai"), a clinical-stage biopharmaceutical company aiming to transform the .